Ovid Therapeutics Inc. · NASDAQ:OVID

ADAR1 Capital Management, LLC reported a 6.90% stake in Ovid Therapeutics Inc. (Schedule 13G)

Event Dec 31, 2025 · Filed Feb 17, 2026

ADAR1 Capital Management, LLC reported a 6.90% stake in Ovid Therapeutics Inc., 9,284,166 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G).

Stake
6.90%
Shares
9,284,166
Intent
Passive
What changed
Crossed above 5%
Filed together
3 holders

The filing in full

HolderStakeShares
ADAR1 Capital Management, LLC6.90%9,284,166
ADAR1 Capital Management GP, LLC6.90%9,284,166
Daniel Schneeberger6.90%9,284,166

Source

View original at SEC

Related